# PET/CT-directed Hyperfractionated Radiation Dose Escalation in Esophageal Cancer

> **NCT03113214** · NA · COMPLETED · sponsor: **Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 27 (actual)

## Conditions studied

- Esophageal Cancer

## Interventions

- **RADIATION:** radiochemotherapy 1
- **RADIATION:** radiochemotherapy 2
- **RADIATION:** radiochemotherapy 3
- **RADIATION:** radiochemotherapy 4
- **RADIATION:** radiochemotherapy 5
- **RADIATION:** radiochemotherapy 6

## Key facts

- **NCT ID:** NCT03113214
- **Lead sponsor:** Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-02
- **Primary completion:** 2019-01-10
- **Final completion:** 2019-02-02
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2019-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03113214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03113214, "PET/CT-directed Hyperfractionated Radiation Dose Escalation in Esophageal Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03113214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*